Purdue Pharma Offers Plan to End Sackler Control and Mounting Lawsuits The OxyContin maker filed its long-awaited restructuring plan in bankruptcy court. Revenue from the new company would go exclusively to abating the opioid crisis. https://ift.tt/2XidLiy https://nyti.ms/3eyQv5F
The OxyContin maker filed its long-awaited restructuring plan in bankruptcy court. Revenue from the new company would go exclusively to abating the opioid crisis.
from NYT > Top Stories https://nyti.ms/3eGffMr
via IFTTT
from NYT > Top Stories https://nyti.ms/3eGffMr
via IFTTT
Comments
Post a Comment